Jazz Pharmaceuticals PLCNASDAQ:JAZZ

Help
Symbol Lookup
    No Matches were found for
    Additional matches for ...
     
    Go
    OverviewChartsNewsFundamentalsEarningsReportsCalendarOptionsTechnical Insight

    Symbol Lookup

    Close

    Search Criteria

    Name or Symbol

    Security Type

    Fund Categories

    Market

    Expiration Filter

    Chain Type

    Submit
    Friday May 24, 2013 5:08 AM ET. Data delayed 15 minutes.
    63.00
    0.00 (0.00%)
    Price HistoryRefresh
    Bid/Lots
    51.51/4
    Ask/Lots
    70.25/2
    Open/Prev Close
    0.00/63.00
    Day Range
    -----
    52-Week Range
    40.38-64.45
    Vol/Avg Daily Vol
    0.0/968.4K

    TD Waterhouse offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

    Open a New Account, or Login if you're a client.

    JAZZ Headlines

    Go
    view headlines only »

    May 13, 2013

    Jazz Pharmaceuticals Announces Participation In Upcoming Investor Events
    9:30PM ET on Monday May 13, 2013 by PR Newswire
    Companies Mentioned: JAZZ

    Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will participate in three upcoming investor events. A live audio webcast of each presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. The events, presentation times and speakers include:

    Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will participate in three upcoming investor events. A live audio webcast of each presentation may be accessed from the Investors section of the Jazz Pharmaceuticals websit...

    May 8, 2013

    Closing Update: Stocks Rally Again, Carried by Strong Earnings at Home, Surprise Rise In Trade Deficit For China
    4:14PM ET on Wednesday May 08, 2013 by Midnight Trader
    Companies Mentioned: JAZZ, AOL, LEDR, TRMD, WBMD, ALXA, TRLA, BTH, REN
    04:14 PM EDT, 05/08/2013 (MidnightTrader) -- U.S. stocks rose Wednesday, lifted by financial and technology shares and carrying the S&P 500 to its fifth advance in a row. Most sectors finished with gains, with utilities the only industry group to po...
    04:14 PM EDT, 05/08/2013 (MidnightTrader) -- U.S. stocks rose Wednesday, lifted by financial and technology shares and carrying the S&P 500 to its fifth advance in a row. Most sectors finished with gains, with utilities the only industry group to...
    Healthcare Stock Inching Higher Just Ahead of Close; CytRx Tumbles After Scrapping Lung-Cancer Drug
    3:54PM ET on Wednesday May 08, 2013 by Midnight Trader
    Companies Mentioned: JAZZ, WBMD, ALXA, CYTR
    03:54 PM EDT, 05/08/2013 (MidnightTrader) -- Top Healthcare Stocks JNJ -0.16% PFE -0.24% ABT +0.42% MRK -0.57% AMGN +0.32% Healthcare stocks are higher today with the NYSE Healthcare Sector Index (^NYP) adding nearly 0.3% while the S&P Healthca...
    03:54 PM EDT, 05/08/2013 (MidnightTrader) -- Top Healthcare Stocks JNJ -0.16% PFE -0.24% ABT +0.42% MRK -0.57% AMGN +0.32% Healthcare stocks are higher today with the NYSE Healthcare Sector Index (^NYP) adding nearly 0.3% while the S&P Healt...
    Sector Update: Healthcare
    3:48PM ET on Wednesday May 08, 2013 by Midnight Trader
    Companies Mentioned: JAZZ, WBMD, ALXA, CYTR
    03:48 PM EDT, 05/08/2013 (MidnightTrader) -- Healthcare stocks are higher today with the NYSE Healthcare Sector Index (^NYP) adding nearly 0.3% while the S&P Healthcare Index (^IXV) is up less than 0.2%. In company news, CytRx Corp (CYTR) is down 9...
    03:48 PM EDT, 05/08/2013 (MidnightTrader) -- Healthcare stocks are higher today with the NYSE Healthcare Sector Index (^NYP) adding nearly 0.3% while the S&P Healthcare Index (^IXV) is up less than 0.2%. In company news, CytRx Corp (CYTR) is dow...
    Healthcare Stocks Inching Higher; WebMD Rallies After Landing Federal-Employee Assistance Contract
    12:40PM ET on Wednesday May 08, 2013 by Midnight Trader
    Companies Mentioned: JAZZ, WBMD, ALXA
    12:40 PM EDT, 05/08/2013 (MidnightTrader) -- Top Healthcare Stocks JNJ -0.55% PFE -0.26% ABT -0.03% MRK -0.29% AMGN -0.11% Healthcare stocks are higher, with the NYSE Healthcare Sector Index (^NYP) adding nearly 0.5% while the S&P Healthcare In...
    12:40 PM EDT, 05/08/2013 (MidnightTrader) -- Top Healthcare Stocks JNJ -0.55% PFE -0.26% ABT -0.03% MRK -0.29% AMGN -0.11% Healthcare stocks are higher, with the NYSE Healthcare Sector Index (^NYP) adding nearly 0.5% while the S&P Healthcare...
    ← Newer123Older →

    Peers Headlines

    Yesterday

    Cubist to Present at Jefferies 2013 Global Healthcare Conference
    12 hours ago by Business Wire
    Companies Mentioned: CBST

    Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Mike Bonney, Cubist's CEO, will present at Jefferies 2013 Global Healthcare Conference on Monday, June 3, to discuss the company's business activities,...

    UPDATE: Alkermes Q4 Results Top Estimates; Shares Rise 1%
    17 hours ago by Midnight Trader
    Companies Mentioned: ALKS
    11:24 AM EDT, 05/23/2013 (MidnightTrader) -- Alkermes (ALKS) is up 1.04% to $32.08 after the integrated biotechnology company reported total Q4 revenues for the quarter were $163.4 million, up from $130.5 million a year prior. Analysts expected $...
    Sector Update: Healthcare Shares Lower In Pre-Market; Celegene Sinks 1% Despite FDA's Priority Review
    20 hours ago by Midnight Trader
    Companies Mentioned: OMER, ALKS, CELG
    08:36 AM EDT, 05/23/2013 (MidnightTrader) -- Healthcare stocks: JNJ: -1.42% PFE: -0.75% ABT: flat MRK: -0.81% AMGN: -1.22% Healthcare shares are lower in pre-market. Celgene (CELG) is down 1.1% although the FDA has granted priority review...
    Sector Update: Healthcare
    20 hours ago by Midnight Trader
    Companies Mentioned: OMER, ALKS, CELG
    08:34 AM EDT, 05/23/2013 (MidnightTrader) -- Healthcare shares are lower in pre-market. Celgene (CELG) is down 1.1% although the FDA has granted priority review to Celgene's Abraxane NDA for treatment of pancreatic cancer. But in postive pre-mar...
    Alkermes Q4 Results Top Estimates
    21 hours ago by Midnight Trader
    Companies Mentioned: ALKS
    07:49 AM EDT, 05/23/2013 (MidnightTrader) -- Alkermes (ALKS) reports total Q4 revenues for the quarter were $163.4 million, up from $130.5 million a year prior. Analysts expected $128 million. Non-GAAP net income increased to $56.3 million, or a ...
    Trade the Earnings: Alkermes Inc
    22 hours ago by Midnight Trader
    Companies Mentioned: ALKS
    06:30 AM EDT, 05/23/2013 (MidnightTrader) -- Earnings Release Date: 05/23/2013 Time: Premarket Avg. Extended-Hours Dollar Volume: $44,060,886 Earnings Sensitivity (up or down): 4.0% Alkermes Inc (ALKS) is due to issue its quarterly earnings repor...

    May 21, 2013

    U.S. RESEARCH ROUNDUP: Microsoft, ICE, Actavis, Boeing
    3:34PM ET on Tuesday May 21, 2013 by Thomson Reuters
    Companies Mentioned: ETFC, EV, HBHC, HD, IBKC, LKFN, HTGC, BIOS, MSFT, CBOE, SCHW, DDD, HHC, URBN, FRC, WFT, ACT, QIHU, LNKD, ICE, AIV, AMD, AMT, AQ, IRG, AZO, BA, BLK, BXS, BZH, CBST, CCL, CME, COH, CONN, CPB, CRAY, DCO, BZ, ECL

    May 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Actavis, and Microsoft...

    Analyst Actions: Cubist Pharmaceuticals Target Raised $4 at Credit Suisse; Shares Up 3.5%, $1 Below New Yr Highs Hit Earlier
    2:19PM ET on Tuesday May 21, 2013 by Midnight Trader
    Companies Mentioned: CBST
    02:19 PM EDT, 05/21/2013 (MidnightTrader) -- Credit Suisse says: Court Sides with CBST in Markman Hearing; Raising Target Price to $56 (from $52) The Judge in the ongoing CBST litigation with Hospira sided with CBST in his Markman hearing rulin...
    Analyst Actions: Cubist Pharmaceuticals Upgraded to Hold at Cantor, PT Raised $9; Shares Flat Early
    7:38AM ET on Tuesday May 21, 2013 by Midnight Trader
    Companies Mentioned: CBST
    07:38 AM EDT, 05/21/2013 (MidnightTrader) -- Cantor Fitzgerald has upgraded Cubist Pharmaceuticals Inc. (CBST) to a Hold rating from a Sell. The firm also raised the target price on the stock to $49 from $40 a share. CBST is steady in the pre-mar...

    May 20, 2013

    U.S. court ruling favors Cubist in patent case vs Hospira
    6:49PM ET on Monday May 20, 2013 by Thomson Reuters
    Companies Mentioned: CBST

    May 20 (Reuters) - A U.S. federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case invo...

    ← Newer1234Older →

    K=Thousands, M=Millions, B=Billions, TTM=Trailing 12 Month, MRQ=Most Recent Quarter, FYR=Fiscal Year End, NM=Not Meaningful, NA=Not Available

    GAAP = Generally Accepted Accounting Principles used in Financial Statements issued by the company, Non-GAAP = Adjusted Operating Earnings or Revenue used in comparison to Analyst Estimates. Adjustments are typically one-time gains or losses

    5:08 AM May 24, 2013
    Copyright ©2013 TD Waterhouse Canada Inc. All rights reserved.
    Privacy Policy | Internet Security | Legal
    Quotes, News, and Fundamentals provided by
    View restrictions
    News provided by